A novel liposomal influenza vaccine (INFLUSOME-VAC) containing hemagglutinin-neuraminidase and IL-2 or GM-CSF induces protective anti-neuraminidase antibodies cross-reacting with a wide spectrum of influenza A viral strains
被引:48
作者:
Babai, I
论文数: 0引用数: 0
h-index: 0
机构:Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, IL-91120 Jerusalem, Israel
Babai, I
Barenholz, Y
论文数: 0引用数: 0
h-index: 0
机构:Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, IL-91120 Jerusalem, Israel
Barenholz, Y
Zakay-Rones, Z
论文数: 0引用数: 0
h-index: 0
机构:Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, IL-91120 Jerusalem, Israel
Zakay-Rones, Z
Greenbaum, E
论文数: 0引用数: 0
h-index: 0
机构:Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, IL-91120 Jerusalem, Israel
Greenbaum, E
Samira, S
论文数: 0引用数: 0
h-index: 0
机构:Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, IL-91120 Jerusalem, Israel
Samira, S
Hayon, I
论文数: 0引用数: 0
h-index: 0
机构:Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, IL-91120 Jerusalem, Israel
Hayon, I
Rochman, M
论文数: 0引用数: 0
h-index: 0
机构:Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, IL-91120 Jerusalem, Israel
Rochman, M
Kedar, E
论文数: 0引用数: 0
h-index: 0
机构:Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, IL-91120 Jerusalem, Israel
Kedar, E
机构:
[1] Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, IL-91120 Jerusalem, Israel
[2] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem, Lab Membrane & Liposome Res, IL-91120 Jerusalem, Israel
[3] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Virol, IL-91120 Jerusalem, Israel
A liposomal influenza vaccine (INFLUSOME-VAC) was developed with the objective of overcoming the major drawbacks of the currently used influenza vaccines: their relatively low efficacy in certain high-risk groups (the elderly, infants, the immunosuppressed) and the need for annual immunization. INFLUSOME-VAC consists of liposomes containing the viral surface proteins hemagglutinin (HA) and neuraminidase (NA) derived from various influenza strains and IL-2 or GM-CSF, as an adjuvant. Vaccination of mice showed that, whereas conventional vaccines induced a low- and short-term response against HA and very low or no anti-NA response, INFLUSOME-VAC produced high titers of both anti-HA and anti-NA antibodies (Abs) in young and old mice that persisted for at least 6 months. Moreover, the anti-NA Abs efficiently cross-reacted with several N2 viral subtypes spanning 20 years. and such vaccines afforded partial protection against heterosubtypic viral infection. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:505 / 515
页数:11
相关论文
共 46 条
[1]
Alving C.R, 1997, NEW GENERATION VACCI, P207
[2]
Askonas B, 1982, BASIC APPLIED INFLUE
[3]
AYMARDHENRY M, 1973, B WORLD HEALTH ORGAN, V48, P199